Achieve life sciences announces publication of cytisinicline vaping cessation trial results in jama internal medicine

Phase 2 orca-v1 trial showed treatment with cytisinicline more than doubled odds of quitting e-cigarettes compared with placebo

ACHV Ratings Summary

ACHV Quant Ranking